Moolec Science SA (NASDAQ:MLEC) Sees Large Decline in Short Interest

Moolec Science SA (NASDAQ:MLEC) was the target of a significant decline in short interest in the month of May. As of May 15th, there was short interest totaling 7,508 shares, a decline of 93.4% from the April 30th total of 114,402 shares. Based on an average daily volume of 36,259 shares, the short-interest ratio is currently 0.2 days. Approximately 1.3% of the shares of the company are sold short.

Moolec Science Stock Up 3.1%

Shares of NASDAQ:MLEC traded up $0.23 on Thursday, reaching $7.48. The company had a trading volume of 10,064 shares, compared to its average volume of 980,560. Moolec Science has a 52-week low of $3.08 and a 52-week high of $126.60. The firm’s 50 day simple moving average is $8.04 and its 200-day simple moving average is $7.58. The firm has a market capitalization of $5.43 million, a PE ratio of -0.23 and a beta of 0.38. The company has a current ratio of 0.15, a quick ratio of 0.08 and a debt-to-equity ratio of 0.79.

Moolec Science (NASDAQ:MLEC) last announced its quarterly earnings results on Thursday, May 14th. The company reported $47.49 earnings per share (EPS) for the quarter. The company had revenue of $2.62 million during the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Moolec Science stock. Citadel Advisors LLC acquired a new position in Moolec Science SA (NASDAQ:MLEC) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned approximately 0.90% of Moolec Science at the end of the most recent reporting period. 0.07% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded Moolec Science from a “sell” rating to a “hold” rating in a report on Saturday, May 16th.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.